Nicholas Haft

Insider Reports History

Location
Somerville, MA
Signature
By: /s/ Matthew P. Blischak, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicholas Haft:

Company Role Class Num Shares Value Price $ Report Date Ownership
Finch Therapeutics Group, Inc. Director Stock Option (right to buy) 10,000 08 Jun 2023 Direct

Insider Reports Filed by Nicholas Haft

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FNCH Finch Therapeutics Group, Inc. 08 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:16
FNCH Finch Therapeutics Group, Inc. 13 Jun 2022 1 $0 4 Director 15 Jun 2022, 17:01
FNCH Finch Therapeutics Group, Inc. 20 Dec 2021 1 +$649,993 4 Director 22 Dec 2021, 17:21